Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.99 USD | +0.17% | -2.16% | +204.06% |
May. 31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+204.06% | 362M | |
+48.53% | 780B | |
+41.27% | 627B | |
-6.37% | 353B | |
+20.93% | 334B | |
+8.21% | 296B | |
+17.60% | 244B | |
-0.98% | 217B | |
+11.39% | 214B | |
+4.40% | 161B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Oppenheimer Adjusts Jasper Therapeutics Price Target to $8 From $21, Maintains Outperform Rating